Kälkner, Karl Mikael
Sundström, Anders http://orcid.org/0000-0003-2337-3371
Nurminen, Marja-Leena
Larsson, Maria
Ljung, Rickard http://orcid.org/0000-0002-0654-4530
Arthurson, Veronica
Article History
Accepted: 22 January 2023
First Online: 14 February 2023
Declarations
:
: No funding was received for the preparation of this letter.
: Anders Sundström reported participating in research funded by governmental agencies, universities, Astellas Pharma, Janssen Biotech, AstraZeneca, Pfizer, Roche, (then) Abbott Laboratories, (then) Schering-Plough, UCB Nordic, and Sobi, with all funds paid to Karolinska Institutet, outside the submitted work. Rickard Ljung reported receiving grants from Sanofi Aventis paid to his institution outside the submitted work; and receiving personal fees from Pfizer outside the submitted work. Karl Mikael Kälkner, Marja-Leena Nurminen, Maria Larsson, and Veronica Arthurson have no conflicts of interest that are directly relevant to the content of this letter.
: The study was approved by the Swedish Ethical Review Authority (2020-06859 and 2021-02186).
: The need for informed consent is regulated in the Swedish Act on ethical review in human research. An informed consent is waived by the Swedish Ethical Review Authority as this is a register-based study.
: Not applicable.
: Aggregated data of adverse drug reaction reports can be found at ExternalRef removed (in Swedish).
: Not applicable.
: Drafting of the manuscript: KMK and RL. Analyses of number of spontaneous reports: ML. Critical revision of the manuscript for important intellectual content: all authors. All authors read and approved the final version<i>.</i>
Free to read: This content has been made available to all.